CELLULAR BASIS FOR THE INEFFICACY OF 5-FU IN HUMAN-COLON CARCINOMA
- 1 December 1985
- journal article
- research article
- Vol. 69 (12) , 1391-1398
Abstract
Five established human colorectal carcinoma cell lines with distinct phenotypic properties were exposed to different concentrations of 5-FU for varying time intervals. Effects were measured by sequential cell counts and by inhibition of colony formation. Treatment for 1 hr with 1 .mu.g/ml barley decreased survival of all cell lines as measured by colony formation; at a concentration of 100 .mu.g/ml, survival was modestly reduced for all cell lines, and forconcentrations of 1000 .mu.g/ml, survival was decreased by > 50%. Extending the length of the treatment interval markedly increased the degree of cell kill for all concentrations of 5-FU. Treatment for > 24 hrs resulted in almost complete extermination of colony-forming cells, even for relatively resistant cell lines. The effect of 5-FU treatment on cell number was more complex and depended on drug concentration, length of treatment, and type of cell line. In general, decrements in cell numbers were somewhat related to both drug concentration and length of treatment interval, especially if performed 7 days after terminating drug tratment. Earlier cell counts were inconclusive and the same result could be obtained for different drug concentrations or treatment intervals. Furthermore, these results would change on a daily basis. More important, cell count results never correlated with the survival endpoint measured by inhibition of colony formation. Our results suggest that enhancement of the currently poor performance of 5-FU in the treatment of human colon carcinoma could originate from changing the administration modality to long-term infusion.This publication has 42 references indexed in Scilit:
- Continuous Infusion or Bolus Injection in Cancer ChemotherapyAnnals of Internal Medicine, 1983
- COMPARISON OF INVITRO METHODS TO DETERMINE DRUG-INDUCED CELL LETHALITY1976
- Correlation between cell enlargement and nucleic acid and protein content of hela cells in unbalanced growth produced by inhibitors of DNA synthesisJournal of Cellular Physiology, 1967
- The physiologic disposition of 5‐fluorouracil and 5‐fluoro‐2′‐deoxyuridine in manClinical Pharmacology & Therapeutics, 1964
- THE CLINICAL EXCURSION INTO 5-FLUOROURACIL1962
- STUDIES ON RESISTANCE AGAINST 5-FLUOROURACIL .1. ENZYMES OF URACIL PATHWAY DURING DEVELOPMENT OF RESISTANCE1962
- COMPARISON OF RAPID AND SLOW INTRAVENOUS ADMINISTRATION OF 5-FLUOROURACIL IN TREATING PATIENTS WITH ADVANCED CARCINOMA OF THE LARGE INTESTINE1962
- GROWTH INHIBITION OF A HUMAN TUMOR CELL STRAIN BY 5-FLUORO-2'-DEOXYURIDINE - TIME PARAMETERS FOR SUBSEQUENT REVERSAL BY THYMIDINE1959
- CYTOCHEMICAL EFFECTS OF 5-FLUOROURACIL ON SENSITIVE AND RESISTANT EHRLICH ASCITES TUMOR CELLS1959
- THE MODE OF ACTION OF 5-FLUOROURACIL AND ITS DERIVATIVESProceedings of the National Academy of Sciences, 1958